Dr Mohamed Bouattour

Spécialité

Onco-hépatologie (thématique, carninome hépatocellulaire, cholangiocarcinome, cancers hépatiques rare)

Hôpital

Hôpital Beaujon (Clichy)

Derniers articles

• Predictors of overall survival in advanced biliary tract cancer in the phase 3 TOPAZ-1 study. (5 janv. 2026)
• Effect of pembrolizumab on viral hepatitis load and transaminases in advanced hepatocellular carcinoma. (24 déc. 2025)
• Cabozantinib for Hepatocellular Carcinoma in Real-World Practice (CLERANCE): A Prospective, Interventional Study. (17 nov. 2025)
• Self-supervised learning to predict intrahepatic cholangiocarcinoma transcriptomic classes on routine histology. (11 nov. 2025)
• Epidemiology, clinical, molecular features, and prognosis of early-onset biliary tract cancer: A systematic review and meta-analysis. (9 oct. 2025)